| Literature DB >> 30967698 |
Vikas Kulshrestha1, Barun Datta1, Gaurav Mittal1, Santhosh Kumar1.
Abstract
BACKGROUND: There has been a gradual increase in the revision TKA (RTKA) workload due to expanding indications of total knee arthroplasty (TKA), coupled with improving patient longevity. Western countries are already looking at their data on RTKA to plan for the future heath care needs of these patients. Limited data is available on RTKA from developing countries. Our study attempts to fill this gap in knowledge.Entities:
Keywords: Aseptic loosening; epidemiology; infection; revision; total knee arthroplasty
Year: 2019 PMID: 30967698 PMCID: PMC6415567 DOI: 10.4103/ortho.IJOrtho_127_17
Source DB: PubMed Journal: Indian J Orthop ISSN: 0019-5413 Impact factor: 1.251
Figure 1Revision total knee arthroplasty workload over 5 years at our institute (2011–2016)
Figure 2Causes of revision total knee arthroplasty
Figure 3Causes of revision as per temporal profile (early, delayed and late failures)
Microbiological studies of infected total knee replacements (culture report and antibiotic sensitivity of organism grown)
| Culture result | ( | ||
|---|---|---|---|
| Culture negative | 65 | ||
| Culture positive | 58 | ||
| Gram positive | 9 | Clindamycin, linezolid, vancomycin, trimethoprim/sulfamethoxaxole, rifampicin | |
| 5 | Linezolid, teicoplanin, vancomycin, trimethoprim/sulfamethoxazole | ||
| 4 | Gentamicin, tigecycline, nitrofurantoin, rifampicin | ||
| 1 | Gentamicin, tigecycline, nitrofurantoin, rifampicin | ||
| 19 | |||
| Gram negative | 4 | ||
| 5 | Amikacin, piperacillin, meropenem | ||
| 11 | Ceftazidime, meropenem, minocycline, septran | ||
| 1 | Trimethoprim/sulfamethoxazole | ||
| 1 | Ampicillin, piperacillin/tazobactam, ceftriaxone, cefepime, imipenem, amikacin, ciprofloxacin | ||
| 7 | Imipenem, meropenem, amikacin, gentamicin, tobramycin, ciprofloxacin, moxifloxacin | ||
| 3 | Ertapenem, meropenem, amikacin, gentamicin, tobramycin | ||
| 1 | Piperacillin/tazobactam | ||
| 3 | Tigecycline, colistin, trimethoprim/sulfamethoxazole | ||
| 3 | Ertapenem, imipenem, meropenem amikacin | ||
| 39 | |||
TKA=Total knee Arthroplasty
Figure 4Temporal and microbiological profile of septic revisions
Summary of recent published literature from developed and developing countries including public health data
| Studies (institutional studies) | Years of operation | Percentage+ | Early revisions$ (%) | Infection (%) | Aseptic loosening and poly wear (%) | Instability (%) | Stiff knee (%) | Fracture (%) | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Sharkey | 2003-2012 | 781 | 10,003 | 7.8 | 38 | 27 | 40 | 8 | 5 | 5 |
| Le | 2001-2011 | 253 | NA | NA | 46 | 24 | 14 | 26 | 18 | 2 |
| Thiele | 2005-2010 | 358 | NA | NA | 46 | 15 | 22 | 22 | NA | NA |
| Schroer | 2010-2011 | 844 | NA | NA | 35 | 16 | 31 | 19 | 7 | NA |
| Dalury | 2000-2012 | 820 | NA | NA | 49 | 18 | 23 | 18 | 9 | NA |
| Callies | 2001-2010 | 1449 | NA | NA | 14 | 32 | 24 | 7 | 5 | 3 |
| Motififard | 2011-2013 | 24 | 353 | 6.8 | 7 | 44 | 9 | 1 | 1 | NA |
| Koh | 2008-2012 | 643 | 20,234 | 3.2 | 0 | 38 | 33 | 7 | 3 | 2 |
| Kasahara | 2006-2011 | 140 | 4047 | 3.4 | NA | 24 | 40 | 9 | NA | 4 |
| Kim | 1992-2012 | 256 | 11,816 | 2.1 | NA | 25 | 45 | 16 | 3 | 3 |
| Hossain | 1999-2008 | 349 | NA | NA | 32 | 33 | 28 | NA | NA | NA |
| Our study (India) | 2011-2015 | 201 | 5068 | 4.0 | 48 | 61 | 18 | 7 | 3 | 5 |
| Bozic | 2005-2010 | NA | NA | NA | NA | 25 | 16 | 10 | NA | 2 |
| Swedish Knee Arthroplasty Register annual report (2011) | 2002-2011 | NA | NA | NA | NA | 27 | 22 | 12 | NA | 2 |
| Bhandari (US health data) | 2010 | NA | NA | NA | NA | 40 | 13 | 20 | 11 | NA |
*Total revision TKA performed, #Total number of TKA performed in the same duration, +Revision workload percentage, $Revisions done within 2 years of index procedure. TKA=Total knee arthroplasty, NA=Not available